Overview

Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure

Status:
NOT_YET_RECRUITING

Trial end date:
2029-08-31

Target enrollment:

Participant gender:

Summary

This is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.

Phase:

PHASE2

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborators:

National Institutes of Health (NIH)
Navy SEAL Foundation
Uniformed Services University of the Health Sciences
University of South Florida